Funding for this research was provided by:
Cancer Research UK (C5066/A8815, C5066/A9541, C5066/A1099)
The Institute of Cancer Research
Received: 31 August 2017
Accepted: 13 February 2018
First Online: 21 February 2018
Ethics approval and consent to participate
: The study of patient materials was conducted according to the principles expressed in the Declaration of Helsinki. The study of rhabdomyosarcoma samples had both local and national ethical approval (Local Research Ethics Committee No 1836 and 2015 and Multi-Regional Research Ethics Committee 98/4/023) and complied with requirements for informed written consent from all patients or their guardians.
: Not applicable
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.